In a more recent study, we found that MMP-11 (also known as stromelysin 3) expression by MICs, and TIMP-2 expression by CAFs, either at the tumor center or at the invasive front, were the most potent independent prognostic factors for predicting the clinical outcome of patients [87]. This evidence concerns the gene MMP11 and neoplasm.